Europe Newborn Screening Market, By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (Germany, France, U.K., Spain, Italy, Switzerland, Netherlands, Russia, Turkey, Belgium, Rest of Europe) Industry Trends and Forecast to 2028.
Europe new born screening market is expected to witness market growth at a rate of 13.42% in the forecast period of 2021 to 2028. Data Bridge Market Research report on Europe newborn screening market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the government initiatives to aware people regarding newborn screening is escalating the growth of Europe newborn screening market.
Newborn screening is known to be the testing that identifies fatal and harmful disorders in newborns which can harmfully disturb their long term health.
Major factors that are expected to boost the growth of the Europe newborn screening market in the forecast period are the rise in the neonatal population base. Furthermore, the increase in the cases of congenital diseases in newborns is further anticipated to propel the growth of the growth of the Europe newborn screening market. Moreover, the suitable government programs and legislations is further estimated to cushion the growth of the Europe newborn screening market. On the other hand, the rise in the expenses of automation technology and the stiff competition offered by small key players is further projected to impede the growth of the Europe newborn screening market in the timeline period.
In addition, the technological developments will further provide potential opportunities for the growth of the Europe newborn screening market in the coming years. However, the dearth of a unified newborn screening policies and procedures around the world might further challenge the growth of the Europe newborn screening market in the near future.
Europe new-born screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe newborn screening market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.
Europe New-born Screening Market Scope and Market Size
Europe new-born screening market is segmented on the basis of test type, product type, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of test type, the Europe newborn screening market is segmented into dried blood spot test, hearing screen test and critical congenital heart diseases (CCHD) test.
- On the basis of product type, the Europe newborn screening market is segmented into instruments, reagents and assay kits.
- On the basis of technology, the Europe newborn screening market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays.
- On the basis of disease type, the Europe newborn screening market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease, others.
- On the basis of end user, the Europe newborn screening market is segmented into paediatric clinics, hospital and clinics.
Europe New-born Screening Market Country Level Analysis
The Europe newborn screening market is analysed, and market size insights and trends are provided by country, type, and end-user as referenced above.
The countries covered in the Europe newborn screening market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
France dominates the Europe newborn screening market due to the five congenital diseases such as sickle cell anemia, phenylketonuria, cystic fibrosis, congenital adrenal hyperplasia and congenital hypothyroidism. Furthermore, the newborn screening activities are financed by the National Public Health Insurance with a motive to provide education on newborn screening on newborn screening on blood spots and to raise the adoption of newborn screening activities is further anticipated to propel the growth of the Europe newborn screening market during the forecast period.
The country section of the Europe newborn screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Europe newborn screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Europe newborn screening market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the Europe newborn screening market. The data is available for the historic period 2010-2019.
Competitive Landscape and Europe Newborn Screening Market Share Analysis
The Europe newborn screening market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the Europe newborn screening market.
The major players covered in the Europe newborn screening market report are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Europe Newborn Screening Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.